{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:16:02Z","timestamp":1784906162319,"version":"3.55.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.juro.2007.01.112","type":"journal-article","created":{"date-parts":[[2007,5,17]],"date-time":"2007-05-17T13:32:02Z","timestamp":1179408722000},"page":"2347-2351","source":"Crossref","is-referenced-by-count":49,"title":["Antitumor Effects of Imidazoquinolines in Urothelial Cell Carcinoma of the Bladder"],"prefix":"10.1097","volume":"177","author":[{"given":"Eric B.","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Urology, New York-Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Department of Urology, New York-Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kawamoto","sequence":"additional","affiliation":[{"name":"Department of Urology, New York-Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueke","family":"You","sequence":"additional","affiliation":[{"name":"Department of Urology, New York-Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Urology, New York-Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, New York-Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Scherr","sequence":"additional","affiliation":[{"name":"Department of Urology, New York-Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2007.01.112_bib1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.01.112_bib2","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1200\/JCO.2003.08.099","article-title":"Intravesical therapy for superficial bladder cancer: slow but steady progress","volume":"21","author":"Lamm","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2007.01.112_bib3","first-page":"4369","article-title":"Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer","volume":"23","author":"Seya","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.juro.2007.01.112_bib4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ni1116","article-title":"Toll-like receptors in the pathogenesis of human disease","volume":"5","author":"Cook","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.juro.2007.01.112_bib5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.juro.2007.01.112_bib6","first-page":"2335","article-title":"Management of genital warts","volume":"70","author":"Kodner","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.juro.2007.01.112_bib7","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1365-4362.2002.01597.x","article-title":"Imiquimod; an international update on therapeutic uses in dermatology","volume":"41","author":"Tyring","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.juro.2007.01.112_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway","volume":"3","author":"Hemmi","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.juro.2007.01.112_bib9","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/01.ju.0000075504.13456.41","article-title":"Detection and quantitative analysis of early stage orthotopic murine bladder tumor using in vivo magnetic resonance imaging","volume":"170","author":"Kikuchi","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.01.112_bib10","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/01.ju.0000101161.17279.09","article-title":"Immunotherapy for urological malignancies","volume":"171","author":"Krejci","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.01.112_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00042307-200309000-00002","article-title":"The current status of intravesical therapy for superficial bladder cancer","volume":"13","author":"Patard","year":"2003","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.juro.2007.01.112_bib12","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jaad.2003.11.066","article-title":"Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies","volume":"505","author":"Geisse","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.juro.2007.01.112_bib13","first-page":"5176","article-title":"Phase I trial of an oral immunomodulator and interferon inducer in cancer patients","volume":"53","author":"Witt","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2007.01.112_bib14","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/djg016","article-title":"Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod","volume":"95","author":"Schon","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"suppl.","key":"10.1016\/j.juro.2007.01.112_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.0366-077X.2003.05632.x","article-title":"Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures","volume":"149","author":"Meyer","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.juro.2007.01.112_bib16","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.0022-202X.2004.22528.x","article-title":"Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod","volume":"122","author":"Schon","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.juro.2007.01.112_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/32183","article-title":"Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs","volume":"392","author":"Albert","year":"1998","journal-title":"Nature"},{"issue":"suppl.","key":"10.1016\/j.juro.2007.01.112_bib18","article-title":"Antigen cross presentation and cross priming in the treatment of superficial bladder cancer: the role of bCG invoked specific CD8+ T cell response against bladder tumor antigens","volume":"171","author":"Smith","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2007.01.112_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/B:APPT.0000025805.55340.c3","article-title":"Immune modulation and apoptosis induction: two sides of the antitumoral activity of imiquimod","volume":"9","author":"Schon","year":"2004","journal-title":"Apoptosis"},{"key":"10.1016\/j.juro.2007.01.112_bib20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1046\/j.1523-1747.1998.00174.x","article-title":"Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463","volume":"110","author":"Imbertson","year":"1998","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534707002509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534707002509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2007.01.112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:55:40Z","timestamp":1784904940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1016\/j.juro.2007.01.112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1016\/j.juro.2007.01.112"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2007.01.112","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}